Replies to post #15052 on General Stock Ideas

[ombowstring]

As of June 29, 2019, Baker Bros. owned approx. 2.24% of the outstanding shares of AXSM -

https://finance.yahoo.com/quote/AXSM/holders?p=AXSM

>>>Baker Brothers Advisors, LLC 772,286 Jun 29, 201 2.24% $19,886,364<<<

Thanks for your previous post on FOMX. I hadn't been aware that >>>Foamix Pharmaceuticals Ltd. has development and license agreements with Bayer HealthCare AG; LEO Pharma A/S; Mylan N.V.; and Actavis plc.<<<

I think it's too bad that you're adamant about not buying individual stocks like AXSM and FOMX because of your disastrous experience with Cortex, PolyMedix, etc. Both of us should have known that biotechs in the very early stages of development have low probabilities of success. However, FOMX has crossed the goal line and AXSM is close to it. Both could be moonshots.